National Community Pharmacists Association
Lobbying group · Jul 2025 – Sep 2026
National Community Pharmacists Association spent $1.2M lobbying the federal government (Jul 2025 – Sep 2026), mostly on medicare & medicaid, pharmacy, health care. It used 4 lobbyists, including people who worked for 1 members of Congress.
- Spent on lobbying
- $1.2M
- Lobbyists
- 4
- Bills lobbied
- 12
- Issues
- 10
Spending by quarter
- 2025 Q3$340K
- 2025 Q4$230K
- 2026 Q1$320K
- 2026 Q2$270K
Issues lobbied
- Medicare & Medicaid
- Pharmacy
- Health care
- Alcohol & drug abuse
- Labor & antitrust
- Defense
- Taxes
- Budget & spending
- Telecom
- Trade
Bills lobbied on
- H.R. 1: One Big Beautiful Bill Act7 reports
- H.R. 3164: Ensuring Community Access to Pharmacist Services Act5 reports
- S. 24264 reports
- H.R. 53164 reports
- S. 5264 reports
- H.R. 22144 reports
- S. 9274 reports
- H.R. 24284 reports
- H.R. 43174 reports
- H.R. 5304: Departments of Labor, Health and Human Services, and Education, and Related Agencies…4 reports
- H.R. 52564 reports
- S. 8914 reports
Lobbying firms hired
- National Community Pharmacists Association$1.2M
- Capitol Counsel LLC$200K
- Bgr Government Affairs$20K
Lobbyists who worked in Congress
- Karen Stone
Office of former Congressman Steve Israel (D-NY) [Legislative Correspondent/Staff Assistant, 2005; Senior Legislative…Dina Titus (D-NV)
Agencies contacted
- House Of Representatives · 41
- Senate · 41
- Health & Human Services, Dept of (Hhs) · 14
- White House Office · 12
- Federal Trade Commission (Ftc) · 8
- Centers For Medicare and Medicaid Services (Cms) · 5
Related
Filings
- 2026 Q2 report$270K
- 2026 Q2 report$50K
- 2026 Q2 report$20K
- 2026 Q1 report$320K
- 2026 Q1 report$50K
From Lobbying Disclosure Act reports filed with the Senate and House.
Cite or embed this page
Capitol Receipts, “National Community Pharmacists Association: Lobbying Spending…,” https://www.capitolreceipts.com/lobbying/cnationalcommunitypharmacistsassociation/national-community-pharmacists-association (accessed 2026-10-17).